Cite
MLA Citation
A Bond et al.. “PTU-049 Concurrent Immunomodulator Therapy does not Influence Infliximab or Adalimumab Trough Levels During Maintenance Therapy.” Gut, vol. 65, n.d., p. A76. http://access.bl.uk/ark:/81055/vdc_100137791740.0x00004a